(Q51812238)

English

Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity.

scientific article published on 21 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

1 reference

based on heuristic

inferred from title

Human metapneumovirus

object named as

human metapneumovirus

1 reference

based on heuristic

inferred from title

Brian R. Murphy

7

object named as

Brian R Murphy

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

author name string

Mario H Skiadopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Stéphane Biacchesi

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Ursula J Buchholz

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Emérito Amaro-Carambot

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Sonja R Surman

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Peter L Collins

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

language of work or name

0 references

publication date

21 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

345

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

492-501

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Genetic diversity between human metapneumovirus subgroups

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Human metapneumovirus infections in hospitalized children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

N-glycosylation contributes to the limited cross-reactivity between hemagglutinin neuraminidase proteins of human parainfluenza virus type 4A and 4B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Human metapneumovirus in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Characterization of human metapneumoviruses isolated from patients in North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Expression of the HN, F, NP and M proteins of Sendai virus by recombinant vaccinia viruses and their contribution to protective immunity against Sendai virus infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Analysis of the genomic sequence of a human metapneumovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.10.016

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/16300813

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51812238&oldid=1826236344"